Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pascal Soriot
Pharma
AstraZeneca CEO outlines conservative forecast model for MFN
During AZ's Q1 call, CEO Pascal Soriot suggested a conservative way to model MFN impact is to remove reference markets from future product forecasts.
Angus Liu
Apr 29, 2026 3:08pm
AZ CEO pay hits $23.9M amid serious 'geopolitical uncertainty’
Feb 24, 2026 11:35am
AZ sets sights on 25+ blockbusters by 2030
Feb 10, 2026 11:20am
AZ will spend $2B to bolster manufacturing presence in Maryland
Nov 21, 2025 3:58pm
AZ CEO: 'We can absorb the impact' of US drug pricing deal
Nov 6, 2025 10:40am
AZ CEO Pascal Soriot talks global 'rebalancing of pricing'
Jul 29, 2025 2:00pm
